Sensei Biotherapeutics, Inc.
SNSE
$12.63
-$0.37-2.85%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 19.71M | 2.79M | 2.32M | 2.67M | 3.55M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 170.63M | 4.96M | 4.85M | 5.21M | 7.27M |
| Operating Income | -170.63M | -4.96M | -4.85M | -5.21M | -7.27M |
| Income Before Tax | -170.24M | -4.72M | -4.57M | -4.94M | -6.86M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -170.24M | -4.72M | -4.57M | -4.94M | -6.86M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -170.24M | -4.72M | -4.57M | -4.94M | -6.86M |
| EBIT | -170.63M | -4.96M | -4.85M | -5.21M | -7.27M |
| EBITDA | -170.60M | -4.92M | -4.82M | -5.17M | -7.24M |
| EPS Basic | -131.45 | -3.74 | -3.62 | -3.91 | -5.45 |
| Normalized Basic EPS | -82.21 | -2.40 | -2.26 | -2.43 | -3.53 |
| EPS Diluted | -131.45 | -3.74 | -3.62 | -3.91 | -5.45 |
| Normalized Diluted EPS | -82.21 | -2.40 | -2.26 | -2.43 | -3.53 |
| Average Basic Shares Outstanding | 1.30M | 1.26M | 1.26M | 1.26M | 1.26M |
| Average Diluted Shares Outstanding | 1.30M | 1.26M | 1.26M | 1.26M | 1.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |